March 5, 2025 - 22:22

Amazon has unveiled its latest palm scan technology at NYU Langone Health, aiming to streamline patient check-in processes. This cutting-edge biometric system allows individuals to check in for appointments simply by scanning their palms, significantly reducing wait times and enhancing the overall patient experience.
The implementation of this technology marks a significant step forward in healthcare innovation, blending convenience with security. Patients can register their palm prints in advance, enabling a quick and seamless check-in upon arrival at the facility. This not only minimizes the need for physical contact but also helps maintain a safer environment in healthcare settings.
The collaboration between Amazon and NYU Langone Health exemplifies the growing trend of integrating advanced technology into patient care. As healthcare providers seek to improve efficiency and patient satisfaction, solutions like palm scanning are becoming increasingly valuable. This initiative is expected to pave the way for broader adoption of biometric technologies in various healthcare institutions across the country.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...